Literature DB >> 10450187

Telomerase expression in intracranial tumours: prognostic potential for malignant gliomas and meningiomas.

M L Falchetti1, R Pallini, L M Larocca, R Verna, E D'Ambrosio.   

Abstract

AIM: To evaluate the diagnostic value of telomerase expression in intracranial tumours.
METHODS: 98 surgical specimens from different neoplasms were analysed by the telomeric repeat amplification protocol (TRAP) and the presence of telomerase compared with the histological diagnosis and the proliferation index.
RESULTS: A high degree of positivity for telomerase activity was found in glioblastomas and atypical/anaplastic meningiomas. Telomerase activity was poorly detected in anaplastic astrocytomas.
CONCLUSIONS: The TRAP assay seems to be a valuable index for identifying meningeal tumours with aggressive behaviour.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10450187      PMCID: PMC501091          DOI: 10.1136/jcp.52.3.234

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  10 in total

1.  Increased sensitivity and reproducibility of TRAP assay by avoiding direct primers interaction.

Authors:  M L Falchetti; A Levi; P Molinari; R Verna; E D'Ambrosio
Journal:  Nucleic Acids Res       Date:  1998-02-01       Impact factor: 16.971

2.  Telomerase activity in ordinary meningiomas predicts poor outcome.

Authors:  L A Langford; M A Piatyszek; R Xu; S C Schold; W E Wright; J W Shay
Journal:  Hum Pathol       Date:  1997-04       Impact factor: 3.466

3.  Origin of concatemeric T7 DNA.

Authors:  J D Watson
Journal:  Nat New Biol       Date:  1972-10-18

Review 4.  The new WHO classification of brain tumours.

Authors:  P Kleihues; P C Burger; B W Scheithauer
Journal:  Brain Pathol       Date:  1993-07       Impact factor: 6.508

5.  Telomerase activity in human brain tumours.

Authors:  L A Langford; M A Piatyszek; R Xu; S C Schold; J W Shay
Journal:  Lancet       Date:  1995-11-11       Impact factor: 79.321

6.  Telomerase activity in gastric cancer.

Authors:  E Hiyama; T Yokoyama; N Tatsumoto; K Hiyama; Y Imamura; Y Murakami; T Kodama; M A Piatyszek; J W Shay; Y Matsuura
Journal:  Cancer Res       Date:  1995-08-01       Impact factor: 12.701

7.  Correlating telomerase activity levels with human neuroblastoma outcomes.

Authors:  E Hiyama; K Hiyama; T Yokoyama; Y Matsuura; M A Piatyszek; J W Shay
Journal:  Nat Med       Date:  1995-03       Impact factor: 53.440

8.  Specific association of human telomerase activity with immortal cells and cancer.

Authors:  N W Kim; M A Piatyszek; K R Prowse; C B Harley; M D West; P L Ho; G M Coviello; W E Wright; S L Weinrich; J W Shay
Journal:  Science       Date:  1994-12-23       Impact factor: 47.728

9.  Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues.

Authors:  A A Avilion; M A Piatyszek; J Gupta; J W Shay; S Bacchetti; C W Greider
Journal:  Cancer Res       Date:  1996-02-01       Impact factor: 12.701

Review 10.  A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group.

Authors:  N L Harris; E S Jaffe; H Stein; P M Banks; J K Chan; M L Cleary; G Delsol; C De Wolf-Peeters; B Falini; K C Gatter
Journal:  Blood       Date:  1994-09-01       Impact factor: 22.113

  10 in total
  7 in total

Review 1.  Telomerase and the endocrine system.

Authors:  Furio Pacini; Silvia Cantara; Marco Capezzone; Stefania Marchisotta
Journal:  Nat Rev Endocrinol       Date:  2011-03-29       Impact factor: 43.330

2.  What We Know about the Molecular Genetics of Central Nervous System (CNS) Tumours in Malaysia.

Authors:  Sarina Sulong; Abdul Aziz Mohamed Yusoff; Norafiza Zainuddin; Jafri Malin Abdullah; Jain George Pannatil; Hasnan Jaafar; Mohd Nizam Isa
Journal:  Malays J Med Sci       Date:  2004-01

3.  Down regulation of human telomerase reverse transcriptase (hTERT) expression by BIBR1532 in human glioblastoma LN18 cells.

Authors:  C Lavanya; Manjunatha M Venkataswamy; M K Sibin; M M Srinivas Bharath; G K Chetan
Journal:  Cytotechnology       Date:  2018-03-15       Impact factor: 2.058

4.  Telomerase activity in pituitary adenomas: significance of telomerase expression in predicting pituitary adenoma recurrence.

Authors:  Atsuo Yoshino; Yoichi Katayama; Takao Fukushima; Takao Watanabe; Chiaki Komine; Takakazu Yokoyama; Kaoru Kusama; Itaru Moro
Journal:  J Neurooncol       Date:  2003-06       Impact factor: 4.130

5.  Telomerase activity in human brain tumors: astrocytoma and meningioma.

Authors:  Majid Kheirollahi; Masoud Mehrazin; Naser Kamalian; Javad Mohammadi-asl; Parvin Mehdipour
Journal:  Cell Mol Neurobiol       Date:  2013-03-20       Impact factor: 5.046

Review 6.  Brain tumors: Special characters for research and banking.

Authors:  Majid Kheirollahi; Sepideh Dashti; Zahra Khalaj; Fatemeh Nazemroaia; Parvin Mahzouni
Journal:  Adv Biomed Res       Date:  2015-01-06

7.  mRNA quantification and clinical evaluation of telomerase reverse transcriptase subunit (hTERT) in intracranial tumours of patients in the island of Crete.

Authors:  A Yannopoulos; E Dimitriadis; A Scorilas; T Trangas; E Markakis; M Talieri
Journal:  Br J Cancer       Date:  2005-07-11       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.